Eris Lifesciences acquires Oaknet Healthcare for Rs 650 crore
The deal will be financed by Rs 300 crore of internal accruals and Rs 350 crore of borrowings
The deal will be financed by Rs 300 crore of internal accruals and Rs 350 crore of borrowings
Eris Lifesciences enters into term loan agreement with Citi Bank
The divested brands include Onabet, Halovate, Sorvate, Luligee, Demelan, Aceret, Dosetil, Revize, and Powercort, and their sub-brands
Witnessing sizable consolidation (M& A) activity with Domestic Formulations and Hospitals being two areas wherein maximum M&A has occurred.
According to the brokerage, as the pandemic has receded, the past exceptional growth in acute therapies may not be repeated (stellar double-digit growth for anti-infectives coming down)
Subscribe To Our Newsletter & Stay Updated